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Acne Impact
Although an association 
between isotretinoin 
therapy and increased risk 
of depression, suicidal 
ideation, and suicide has 
been proposed, supportive 
data are lacking, and the link 
between these psychological 
problems and severe acne 
has not been properly 
investigated. Halvorsen 
and colleagues therefore 
performed a cross-sectional 
questionnaire-based study 
of 3,755 adolescents. The 
results suggest that the 
higher rates of reported 
suicidal ideation, mental 
health problems, and social 
impairment in adolescents 
who are candidates for 
isotretinoin treatment may 
stem from the burden of acne 
and not necessarily from the 
treatment. See page 363
Melanoma, Take 2
Improved survival rates and 
increased life expectancy 
accompany an increased risk 
of subsequent melanoma 
tumor development in 
primary melanoma patients. 
Siskind and colleagues 
found that the high risk of 
developing a second primary 
tumor was highest for 
patients with large numbers 
of nevi and with a higher 
than average familial history 
of melanoma. Also, red-hair 
phenotype and fair skin 
contributed moderately to 
this risk. Because these factors 
are assessable at the time of 
primary melanoma diagnosis, 
patients may be advised of 
their risk for subsequent 
melanoma at that time.  
See page 461
Molecular Scar
Treatment of psoriasis often results in the resolu-
tion of the clinical and histopathological features of 
lesions; however, lesions often recur within weeks to 
months after cessation of treatment. Suárez-Fariñas 
and colleagues used microarray analysis to describe 
a residual disease genomic profile in lesional skin 
from psoriasis patients who responded to treatment 
with etanercept. Inflammation was not completely 
resolved in treated lesions, residual dermal CD8+ cells 
remained, and structural cells in the skin continued to 
express molecular alterations. Thus, the histo logical 
resol ution of lesions is not accompanied by full molec-
ular resolution, suggesting the remnants of a molecular 
scar under lying the recurrence of lesions at the same 
locations. See page 391
Risks for ABNOM
The etiology of the recently described 
pigmentary disorder acquired bilateral 
nevus-of-Ota-like macules (ABNOM) is 
poorly understood. Wang and colleagues 
performed a large population-based study 
of 8,680 subjects in China to elucidate 
the epidem iology of this treatment-refrac-
tory disease. Interestingly, the prevalence 
of ABNOM was significantly higher in 
women (4.2%) than in men (0.5%). In 
addition, the prevalence in women was associated with age, with the highest rates 
occurring after puberty (>15 years) and before menopause (<50 years). These findings 
implicate female hormones in the pathogenesis of this disease. See page 358
Maintained Genetic Load
Using deep-sequencing techno-
logy to cover the coding exons 
of the p53 gene in individual 
epidermal clones of human skin, 
Ståhl and colleagues found that 
persistent nonsynonymous p53 
mutations accumulate in inter-
mittently sun-exposed skin at 
rates as high as 35,000 per year 
per individual. Because no signs 
of UV-shielding effects were observed between sun-exposed and recently shielded skin 
samples, the authors suggest that clones carrying a p53 mutation originated from a sin-
gle proliferating cell that remained from previous years of sun exposure. Furthermore, 
the high frequency of nonsynonymous mutations in phenotypically intact epidermal cell 
compartments calls into question the perceived dominant negative role of the p53 gene. 
See page 504
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